HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.

AbstractBACKGROUND:
In dialysis patients, the prevalence of thyroid disorders and their impact on specific cardiovascular (CV) events and mortality are largely unknown. The aim of the present study was to analyze whether subclinical thyroid disorders were associated with CV events and mortality.
STUDY DESIGN:
Prospective multicenter cohort study.
SETTING & PARTICIPANTS:
Thyroid status and clinical outcomes were explored in 1,000 diabetic hemodialysis patients from 178 centers in Germany.
PREDICTOR:
Thyroid status, defined by the following cutoff values: euthyroidism (thyrotropin [TSH], 0.30-4.0 mIU/L; free triiodothyronine [T3], 2.7-7.6 pmol/L; and free thyroxine [T4], 11.0-24.0 pmol/L), subclinical hyperthyroidism (TSH<0.3 mIU/L and free T3/free T4 within reference ranges), subclinical hypothyroidism (TSH, 4.1-15.0 mIU/L and free T3/free T4 within reference ranges), euthyroid sick syndrome (free T3<2.7 pmol/L and TSH/free T4 low or within reference ranges).
OUTCOMES:
During 4 years' follow-up, prespecified adjudicated end points were determined: sudden cardiac death, myocardial infarction, stroke, combined CV events, and overall mortality. Short-term effects within the first 12 months were contrasted to long-term effects (years 2-4).
MEASUREMENTS:
TSH, free T3, and free T4 levels at baseline.
RESULTS:
Euthyroidism was present in 78.1% of patients; subclinical hyperthyroidism, in 13.7%; and subclinical hypothyroidism, in 1.6%. Euthyroid sick syndrome was exhibited by 5.4% of patients. The adjusted short-term risk of sudden cardiac death was more than doubled (HR, 2.03; 95% CI, 0.94-4.36) in patients with subclinical hyperthyroidism, and similarly for patients with euthyroid sick syndrome (HR, 2.74; 95% CI, 0.94-7.98) compared with patients with euthyroidism. Short-term mortality was increased almost 3-fold for patients with euthyroid sick syndrome (HR, 2.97; 95% CI, 1.66-5.29), but this effect was not seen in the long term. Subclinical hypothyroidism was not associated with CV events or all-cause mortality. Risks of stroke and myocardial infarction were not affected meaningfully by thyroid disorders.
LIMITATIONS:
Observational study design.
CONCLUSIONS:
Sudden cardiac death may be influenced by subclinical hyperthyroidism and euthyroid sick syndrome in the short term. Furthermore, euthyroid sick syndrome is associated strongly with mortality in hemodialysis patients. Regular assessment of thyroid status may help estimate the cardiac risk of dialysis patients.
AuthorsChristiane Drechsler, Andreas Schneider, Lena Gutjahr-Lengsfeld, Matthias Kroiss, Juan Jesús Carrero, Vera Krane, Bruno Allolio, Christoph Wanner, Martin Fassnacht
JournalAmerican journal of kidney diseases : the official journal of the National Kidney Foundation (Am J Kidney Dis) Vol. 63 Issue 6 Pg. 988-96 (Jun 2014) ISSN: 1523-6838 [Electronic] United States
PMID24315768 (Publication Type: Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
Topics
  • Aged
  • Arrhythmias, Cardiac (epidemiology)
  • Death, Sudden, Cardiac (epidemiology)
  • Diabetes Mellitus, Type 2 (epidemiology)
  • Diabetic Nephropathies (epidemiology, physiopathology, therapy)
  • Euthyroid Sick Syndromes (epidemiology, physiopathology)
  • Female
  • Humans
  • Hyperthyroidism (epidemiology, physiopathology)
  • Hypertrophy, Left Ventricular (epidemiology)
  • Hypothyroidism (epidemiology, physiopathology)
  • Male
  • Middle Aged
  • Prospective Studies
  • Renal Dialysis
  • Risk Factors
  • Thyroid Diseases (epidemiology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: